Cabometyx Approved for Treatment of Advanced Renal Cell Cancer Kidney Cancer

Cabometyx™ Approved for Treatment of Advanced Renal Cell Cancer (Kidney Cancer)

17:18 EST 8 Feb 2019 | Cancer Connect

The kinase inhibitor Cabometyx™ is effective treatment as initial and or second line treatment of advanced kidney cancer

More From BioPortfolio on "Cabometyx™ Approved for Treatment of Advanced Renal Cell Cancer (Kidney Cancer)"